FAKTOR-OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Delayed Deutsche Boerse AG 12:00:16 2024-05-23 pm EDT | ||
| 2.84 EUR | +8.81% |
|
| Current month | -26.89% | ||
| 1 month | -19.94% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 2.84 | +8.81% |
| 24-05-22 | 2.61 | -0.38% |
| 24-05-21 | 2.62 | -3.32% |
| 24-05-20 | 2.71 | -2.52% |
| 24-05-17 | 2.78 | +5.70% |
Delayed Quote Deutsche Boerse AG
Last update May 23, 2024 at 12:00 pm EDT
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SV12L3 |
| ISIN | DE000SV12L30 |
| Date issued | 2023-03-15 |
| Strike | 76.77 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.08 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.7 € |
|---|---|
| Lowest since issue | 2.14 € |
| Spread | 0.01 € |
| Spread % | 0.35% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.21
USD
Average target price
96.16
USD
Spread / Average Target
+6.60%
- Stock Market
- Certificates
- Certificat
